Results 151 to 160 of about 39,695 (260)

Cost-Effectiveness of Infant Pneumococcal Conjugate Vaccination Strategies in Vietnam: A Stepwise Economic Evaluation. [PDF]

Vaccines (Basel)
Huang L, Ta A, Antonov A, Groff M, Nguyen PL.   +4 more
europepmc   +1 more source

Application of the WHO new vaccine introduction prioritisation and sequencing framework to guide evidence-based vaccine introduction decisions in Iran, 2025-2030. [PDF]

BMJ Open
Fotouhi A, Younesian S, Mousavi SM, Zahraei SM, Mahmoudi S, Fotouhi F, Nojomi M, Alavi M, Zamani O, Sedighi I, Nateghian A, Akbari Sari A, Movahedi M, Gharagozlou M, Mamishi S, Salehi M, Biglari A, Es-Haghi A, Moradi G, Gouya MM.   +19 more
europepmc   +1 more source

Development and validation of immunological assays for preclinical evaluation of a novel bivalent typhoid conjugate vaccine. [PDF]

Hum Vaccin Immunother
Gavade V, Kamat C, Avalaskar N, Haridasyam V, Sargar S, Chavan A, Jadhav V, Kadam S, Borude B, Sarma AD, Mallya A, Dhere RM.   +11 more
europepmc   +1 more source

The missing link in combating antimicrobial resistance: leveraging vaccines for prevention. [PDF]

Antimicrob Resist Infect Control
Lao PE, Conda LE, Joshi J, Ortiz de Leo MJ, Sreenivasan N, Plant L, Fleck-Vidal C, Apostol GLC.   +7 more
europepmc   +1 more source

Using Synthetic Glycans to Investigate Anti‐Glycan Antibodies and Explore Their Medical Potential

Angewandte Chemie International Edition, EarlyView.
Anti‐glycan antibodies are essential in health and disease. Access to novel glycan structures paves the way for progress in antibody profiling for biomarker discovery, antibody development, and vaccine design. We summarize the strategies to synthesize and utilize synthetic glycans for the development and application of anti‐glycan antibodies in basic ...
Fabienne Weber, Aina Valenti, Jiří Ledvinka, Oren Moscovitz, Peter H. Seeberger   +4 more
wiley   +1 more source

Measuring vaccine effects on antibiotic use and antimicrobial resistance in low and middle-income countries: A scoping review of methodological approaches, data sources, metrics, and limitations. [PDF]

PLOS Glob Public Health
Iwu-Jaja C, Iwu CD, Jaca A, Wiysonge CS.
europepmc   +1 more source

HIV-Specific vs Universal Immunization Coverage in US Children with HIV: A Multi-Site Study. [PDF]

J Pediatric Infect Dis Soc
Sabet S, Hollman N, Hendrix-Dicken A, Raschka M, La N, Oldham MM, Richardson J, Schmidt D, Carr S, Atkins A, Williams MB.   +10 more
europepmc   +1 more source

Circular Photocaged mRNA for Light‐induced Late‐stage Activation of Translation

Angewandte Chemie International Edition, EarlyView.
A clickable photo‐caged 5′ cap (CyCliCap) allows to make Cyclic Click Cap‐containing mRNA (CyCliCap‐mRNA) which is remarkably stable and translationally muted until irradiated, allowing for late‐stage activation of translation in cells by light. ABSTRACT mRNA is a new medical modality as vaccine and raises hopes to become a protein replacement agent ...
Bayram Terzi, Greta Charlotte Dahm, Kristoffer Heintz, Martin Sumser, Yasuaki Kimura, Hiroshi Abe, Andrea Rentmeister   +6 more
wiley   +1 more source

Preclinical evaluation of a bivalent conjugate vaccine against <i>Salmonella</i> Typhi and Paratyphi A. [PDF]

Front Immunol
Alfini R, Di Benedetto R, Carducci M, Paradkar V, Mallubhotla H, Renukuntla S, Patel D, Manoharan S, Panchakshari M, Kyasani M, Sengupta N, Martin LB, Rossi O, Rondini S, Giannelli C, Micoli F.   +15 more
europepmc   +1 more source

Not just another shot: Tailoring vaccination in the era of modern liver transplantation. [PDF]

World J Transplant
Papic N, Kosuta I, Ljubas D, Vrsaljko N, Sesa V, Domislovic V, Ahsan S, Mrzljak A.   +7 more
europepmc   +1 more source